Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 7/20 | 0.82 |
| ▸ | CNR1 | P21554 | 2/20 | 0.82 |
| ▸ | CNR2 | P34972 | 2/20 | 0.82 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.82 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.82 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.82 |
| ▸ | INHA | P05111 | 1/20 | 0.82 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.82 |
| ▸ | HTR2A | P28223 | 1/20 | 0.82 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.82 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.82 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.82 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.82 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.82 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.82 |
| ▸ | TRPV2 | Q9Y5S1 | 1/20 | 0.82 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.67 |
| ▸ | BACE1 | P56817 | 1/20 | 0.67 |
| ▸ | MAOB | P27338 | 6/20 | 0.58 |
| ▸ | APP | P05067 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6856702 | 1.00 | PPARG (0.82) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL17345392 | 0.92 | PPARG (0.70) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23523476 | 0.92 | PPARG (0.92) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL19422415 | 0.92 | PPARG (0.92) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| Cannabigerol SCHEMBL144819 | 0.90 | PPARG (1.00) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| Cannabigerol SCHEMBL14764730 | 0.90 | PPARG (1.00) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| Cannabigerol SCHEMBL12954626 | 0.90 | PPARG (1.00) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23522969 | 0.89 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23523543 | 0.89 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23523454 | 0.89 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021127559-A1 | COMPOSITIONS COMPRISING CANNABINOID ANIONS AND ANTI-NUCLEATING AGENTS | Natural Extraction Systems, LLC (US) | 2021-06-24 | — | — | WO | claimed |
| WO-2021097150-A1 | METHODS OF PREVENTING AND TREATING HEALTH CONDITIONS USING CANNABINOID ANIONS | Natural Extraction Systems, LLC (US) | 2021-05-20 | — | — | WO | claimed |
| WO-2021097163-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING CANNABINOID ANIONS | Natural Extraction Systems, LLC (US) | 2021-05-20 | — | — | WO | claimed |
| WO-2021041637-A1 | COMPOSITIONS COMPRISING CANNABINOID IONS DISSOLVING IN GLYCEROL | Natural Extraction Systems, LLC (US) | 2021-03-04 | — | — | WO | claimed |
| US-10807931-B2 | Synthesis of phytocannabinoids including a decarboxylation step | THE UNIVERSITY OF SYDNEY (AU) | 2020-10-20 | — | — | US | claimed |
| US-20200172459-A1 | SYNTHESIS OF PHYTOCANNABINOIDS INCLUDING A DECARBOXYLATION STEP | THE UNIVERSITY OF SYDNEY (AU) | 2020-06-04 | — | — | US | claimed |
| US-20260083161-A1 | CONTAINERS THAT CONTAIN ANIONIC CANNABINOIDS | NATURAL EXTRACTION SYS LLC (US) | 2026-03-26 | — | — | US | disclosed |
| US-12484606-B2 | Compositions and methods related to anionic cannabinoid molecules | Natural Extraction Systems, LLC (US) | 2025-12-02 | — | — | US | disclosed |
| EP-2961402-B1 | BIOSYNTHESIS OF CANNABINOIDS | TEEWINOT TECH LIMITED (IE) | 2024-10-02 | — | — | EP | disclosed |
| US-20230190670-A1 | COMPOSITIONS COMPRISING NOVEL CANNABINOID AND TERPENE PROFILES | Natural Extraction Systems, LLC (US) | 2023-06-22 | — | — | US | disclosed |
| US-20230172899-A1 | CANNABINOID COMPOSITIONS | THE QUEEN'S MEDICAL CENTER | 2023-06-08 | — | — | US | disclosed |
| US-20230091336-A1 | CANNABINOID COMPOSITIONS | THE QUEEN'S MEDICAL CENTER | 2023-03-23 | — | — | US | disclosed |
| US-20230059582-A1 | CANNABINOID DERIVATIVES | CANOPY GROWTH CORPORATION (CA) | 2023-02-23 | — | — | US | disclosed |
| US-20160340629-A1 | APPARATUS AND METHODS FOR BIOSYNTHETIC PRODUCTION OF CANNABINOIDS | FULL SPECTRUM LABORATORIES LIMITED (IE) | 2016-11-24 | — | — | US | disclosed |
| US-20160264917-A1 | APPARATUS AND METHODS FOR THE SIMULTANEOUS PRODUCTION OF COMPOUNDS | FULL SPECTRUM LABORATORIES LIMITED (IE) | 2016-09-15 | — | — | US | disclosed |
| US-9394510-B2 | Apparatus and methods for the simultaneous production of compounds | FULL SPECTRUM LABORATORIES LIMITED (IE) | 2016-07-19 | — | — | US | disclosed |
| US-9359625-B2 | Chemical engineering processes and apparatus for the synthesis of compounds | FULL SPECTRUM LABORATORIES LIMITED (IE) | 2016-06-07 | — | — | US | disclosed |
| WO-2016030828-A1 | APPARATUS AND METHODS FOR THE SIMULTANEOUS PRODUCTION OF CANNABINOID COMPOUNDS | FULL SPECTRUM LABORATORIES LIMITED (IE) | 2016-03-03 | — | — | WO | disclosed |
| US-20160053220-A1 | APPARATUS AND METHODS FOR THE SIMULTANEOUS PRODUCTION OF COMPOUNDS | FULL SPECTRUM LABORATORIES LIMITED (IE) | 2016-02-25 | — | — | US | disclosed |
| US-20150361469-A1 | CHEMICAL ENGINEERING PROCESSES AND APPARATUS FOR THE SYNTHESIS OF COMPOUNDS | FULL SPECTRUM LABORATORIES LIMITED (IE) | 2015-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200172459-A1 | SYNTHESIS OF PHYTOCANNABINOIDS INCLUDING A DECARBOXYLATION STEP | CNR2, CNR1, CCNB1 | PPARG 1757/4885CNR1 2/4885CNR2 1/4885 |
| US-20230172899-A1 | CANNABINOID COMPOSITIONS | CNR2, CNR1, GPR18 | PPARG 333/4885CNR1 2/4885CNR2 1/4885 |
| US-20260083161-A1 | CONTAINERS THAT CONTAIN ANIONIC CANNABINOIDS | CNR2, CNR1, OPRD1 | PPARG 966/4885CNR1 2/4885CNR2 1/4885 |
| US-20230059582-A1 | CANNABINOID DERIVATIVES | CNR2, CNR1, GPR18 | PPARG 137/4885CNR1 2/4885CNR2 1/4885 |
| US-12484606-B2 | Compositions and methods related to anionic cannabinoid molecules | CNR2, CNR1, PHOSPHO1 | PPARG 372/4885CNR1 2/4885CNR2 1/4885 |
| US-20230091336-A1 | CANNABINOID COMPOSITIONS | CNR2, CNR1, GPR18 | PPARG 255/4885CNR1 2/4885CNR2 1/4885 |
| US-10807931-B2 | Synthesis of phytocannabinoids including a decarboxylation step | CNR2, CNR1, CCNB1 | PPARG 1757/4885CNR1 2/4885CNR2 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.